SCHEDULE: Opus Genetics: Bios Funds Report 4.53% Stake
Beneficial Ownership Filing
Several Bios-affiliated entities and individuals have reported a combined beneficial ownership of 4.53% in Opus Genetics, Inc. common stock.
Summary
- The filing indicates that various entities and individuals associated with Bios, including Bios Fund III, Bios Fund III QP, Bios Fund III NT, Bios Equity III, Cavu Management, Bios Management, Cavu Advisors, Bios Advisors, Aaron G.L. Fletcher, and Leslie W. Kreis, collectively beneficially own 3,683,429 shares of Opus Genetics, Inc. common stock.
- This represents 4.53% of the total outstanding shares.
- The reporting date for this event is May 12, 2026.
- The percentage is based on 81,395,539 shares outstanding as of May 7, 2026, as reported in Opus Genetics' Form 10-Q filed on May 12, 2026.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it reports on existing ownership stakes rather than new financial results or strategic changes.
Future Outlook
This filing is a Schedule 13G, which reports beneficial ownership and does not contain forward-looking statements or guidance regarding future performance.
Industry Context
StockSavvy.ai notes that Schedule 13G filings are routine disclosures for significant institutional investors and do not inherently signal a change in company strategy or performance, but rather a change in ownership stake.
Key Dates
| Date | Description |
|---|---|
| 2026-05-07 | Date of outstanding shares as reported in Issuer's Current Report on Form 10-Q. |
| 2026-05-12 | Date of Event Which Requires Filing of this Statement. |
| 2026-05-12 | Date of Issuer's Current Report on Form 10-Q. |
| 2026-05-13 | Date of signature for the filing. |
Keywords
Opus Genetics, Schedule 13G, Beneficial Ownership, Bios Funds, Investment, SEC Filing, Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.